There is a chance for the scientists from Hamburg to receive more effective drug developed against cancer. As per the speech by Dr Ilona Schonn, Director of Cell Culture Research at Indivumed GmbH, there is the development of Pre-Clinical Trial Platform of a certain drug testing to analyze tumor tissue in patient on molecular level of the drug response.
Mostly, there used liver, kidney or lung tissue slices to test metabolism and toxicity of drugs. The new trial is applied on usage of colorectal and lung cancer patients’ tumor tissues.
Nowadays the scientists are dumped with the issue in preclinical trials of patients’ cell models as a extrapolate response. Dr. Schonn explained that about 90% of clinical tests were failed with the reason of toxicity of ineffectiveness of the examined drugs. And the issue is not only in high cost of the research in the drug development but high risk given by toxicity to the patients and even the patients’ time spending for the testing that gave ineffective response. Continue reading ‘New Cancer Medicine Test’ »